Fig. 01 -

Title Slide

Fig. 02 -

Disclosures

Fig. 03 -

Overview

Fig. 04 -

Themes

Fig. 05 -

Ideal Marker

Fig. 06 -

Urine Markers

Fig. 07 -

Tumor Marker

Fig. 08 -

Meta-analyses

Fig. 09 -

Low Grade

Fig. 10 -

High Grade

Fig. 11 -

Urinary Markers

Fig. 12 -

Main Limitations

Fig. 13 -

Predictive Value

Fig. 14 -

Impact of Prevalence

Fig. 15 -

Intended Uses

Fig. 16 -

Specialized Uses

Fig. 17 -

Clinical Scenarios

Fig. 18 -

Missed Cancer

Fig. 19 -

Marker Use

Fig. 20 -

Cystoscopy / Cytology

Fig. 21 -

Reflex Testing

Fig. 22 -

Anticipatory Positives

Fig. 23 -

Multicenter Evaluation

Fig. 24 -

NC and PM

Fig. 25 -

Options

Fig. 26 -

Reduce Number

Fig. 27 -

Alternating Markers

Fig. 28 -

FISH

Fig. 29 -

Investigational Markers

Fig. 30 -

Conclusions